LY3841136
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for LY3841136, covering 2025-08-28 to 2026-06-24. Get the full timeline:
Most recent: Clinical Trial Results: A Study of LY3841136 Compared With Placebo in Adult Participants With Obesity or Overweight [Phase 2]